Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2011. The report details a specific share repurchase transaction executed on October 11, 2011, in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure and share repurchase activity.
- Shares Purchased: 200,000 Ordinary shares of 25 pence each.
- Price Range: Highest price paid was 1,390 pence per share; lowest price paid was 1,380 pence per share.
- Treasury Holdings (Settled): 506,126,370 shares (9.09% of total issued share capital).
- Treasury Holdings (Including Unsettled): 506,626,370 shares (10.00% of current total voting rights).
- Shares in Issue (Excluding Treasury): 5,063,762,641 shares.
Material Changes
The primary material change reported is the increase in the Company's treasury share holdings following the purchase of 200,000 shares. This transaction increased the percentage of total voting rights held in treasury to exactly 10.00% when including shares purchased but not yet settled.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase or subscribe for securities.
Key Facts for Investor Verification
- Verify the total number of shares in issue (5,063,762,641) to calculate individual ownership percentages under Disclosure and Transparency Rules.
- Confirm the current treasury holding percentage (10.00% of voting rights) for corporate governance assessments.
- Note that the repurchase price range (1,380-1,390 pence) reflects market conditions on October 11, 2011.
- Understand that this filing does not contain operational or financial performance data for the period.